Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Works matching IS 11980052 AND DT 2012 AND VI 19 AND IP 1
Results: 16
1
2
Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. e9, doi. 10.3747/co.19.891
- By:
- Publication type:
- Article
3
Cancer control: life and death in an unequal world.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
4
Medullary thyroid cancer and pseudocirrhosis: case report and literature review.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
5
Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
6
Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. 36, doi. 10.3747/co.19.895
- By:
- Publication type:
- Article
7
Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. e16, doi. 10.3747/co.19.871
- By:
- Publication type:
- Article
8
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. e1, doi. 10.3747/co.19.979
- By:
- Publication type:
- Article
9
Phase I study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. e28, doi. 10.3747/co.19.866
- By:
- Publication type:
- Article
10
Major histocompatibility complex class I and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. 39, doi. 10.3747/co.19.945
- By:
- Publication type:
- Article
11
E-MANUSCRIPT ARTICLE SUMMARIES.
- Published in:
- 2012
- Publication type:
- Abstract
12
Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Letter
13
A call for action in survivorship research and care.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
14
Challenges in knowledge translation: the early years of Cancer Care Ontario's Program in Evidence-Based Care.
- Published in:
- Current Oncology, 2012, v. 19, n. 1, p. 27, doi. 10.3747/co.19.985
- By:
- Publication type:
- Article
15
A model for breast cancer risk based on stem-cell theory.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
16
EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions.
- Published in:
- 2012
- By:
- Publication type:
- Editorial